Friday, June 27, 2014

Afrezza, a New Inhaled Insulin, Is Approved by the F.D.A.

The approval is a huge milestone for MannKind Corporation, but concerns linger about the drug’s potential effect on patients’ lungs.


via NYT > Health http://ift.tt/1pZ1qbt








via All Health and Fitness http://ift.tt/1jtZMbP
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)